What is TIBA?
Tackling Infections to Benefit Africa (TIBA, which means “to cure an infection” in Swahili) is an Africa-led, wide-ranging, multi-disciplinary research programme that explores and draws lessons from the ways that different African health systems tackle infectious diseases. Through TIBA, the University of Edinburgh will be working in partnerships with researchers from Botswana, Ghana, Kenya, Rwanda, South Africa, Sudan, Tanzania, Uganda and Zimbabwe to generate new knowledge and inform comparative analyses of health systems.
To harness the expertise and technical capability in biomedical and social sciences at the University of Edinburgh (UoE) and African partners to reduce the burden and threat of infectious diseases in Africa by informing and influencing health policy and strengthening health systems.
These aims will be delivered by collaborative and coordinated activities organised as 6 work packages:
Our science, budget and impact
Disciplines - infection biology, clinical medicine, primary health care, health systems, international development, governance and ethics, diagnostics, surveillance and epidemiology, molecular biology and drug development, immunology and vaccinology, genomics and bioinformatics, synthetic biology, innovation.
Diseases - schistosomiasis, malaria, trypanosomiasis, lymphatic filariasis, co-morbidities, NCDs + emerging infectious diseases.
Budget: We have a budget of just under £7M over a 4 year period plus in kind contributions. More than 80% of this will be allocated to our African partners.
Impact: Partner countries population total ≈ 300M; Population living in poverty ≈ 75M; Health care spend (public funds) ≈ US$20B; TIBA beneficiaries’ ≈ 50M people. Achieved by: improving health policy, health systems operation and health R&D environment in Africa partner countries and beyond.